Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The price of Origin Materials Inc (NASDAQ: ORGN) closed at $0.53 in the last session, up 3.27% from day before closing price of $0.52. In other words, the price has increased by $3.27 from its previous closing price. On the day, 0.89 million shares were traded. ORGN stock price reached its highest trading level at $0.537 during the session, while it also had its lowest trading level at $0.495.
Ratios:
We take a closer look at ORGN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.33 and its Current Ratio is at 6.37. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for the company, BofA Securities on January 14, 2025, Downgraded its rating to Underperform and sets its target price to $1.50 from $2.50 previously.
On August 16, 2024, BofA Securities Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $1.35 to $3.
Craig Hallum Downgraded its Buy to Hold on August 11, 2023, while the target price for the stock was maintained at $2.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 03 ’25 when Plavan Matthew T sold 150,000 shares for $0.55 per share. The transaction valued at 82,500 led to the insider holds 1,360,231 shares of the business.
MATT PLAVAN bought 150,000 shares of ORGN for $78,993 on Nov 03 ’25. On Aug 21 ’25, another insider, Lee Joshua C., who serves as the General Counsel of the company, sold 3,860 shares for $0.56 each. As a result, the insider received 2,177 and left with 689,084 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORGN now has a Market Capitalization of 79911064 and an Enterprise Value of 16395757. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.79 while its Price-to-Book (P/B) ratio in mrq is 0.26. Its current Enterprise Value per Revenue stands at 0.572 whereas that against EBITDA is -0.308.
Stock Price History:
The Beta on a monthly basis for ORGN is 0.95, which has changed by -0.5868217 over the last 52 weeks, in comparison to a change of 0.12121439 over the same period for the S&P500. Over the past 52 weeks, ORGN has reached a high of $1.36, while it has fallen to a 52-week low of $0.40. The 50-Day Moving Average of the stock is -6.01%, while the 200-Day Moving Average is calculated to be -18.39%.
Shares Statistics:
According to the various share statistics, ORGN traded on average about 1.19M shares per day over the past 3-months and 1049260 shares per day over the past 10 days. A total of 150.17M shares are outstanding, with a floating share count of 134.68M. Insiders hold about 10.26% of the company’s shares, while institutions hold 11.20% stake in the company. Shares short for ORGN as of 1760486400 were 3031195 with a Short Ratio of 2.54, compared to 1757894400 on 3283454. Therefore, it implies a Short% of Shares Outstanding of 3031195 and a Short% of Float of 2.0599999.
